Immunic, Inc. is trading at $12.76 (+5.76%), rebounding from a sharp two-day pullback despite a lack of company-specific news or regulatory updates.
- The stock appears to be tracking broader market strength, with the S&P 500 up 0.71% and the Nasdaq up 0.91%.
- The move follows a weak prior session, suggesting the recovery is driven by risk-on sentiment rather than a fundamental catalyst.